Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.

Citation: Procopiou PA, Ford AJ, Graves RH, Hall DA, Hodgson ST, Lacroix YM, Needham D, Slack RJ.: Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation. Bioorg Med Chem Lett, Volume 22 (8), 2012
Authors: Ford AJ, Graves RH, Hall DA, Hodgson ST, Lacroix YM, Needham D, Procopiou PA, Slack RJ.
Journal: Bioorg Med Chem Lett
Year: 2012
DOI: 10.1016/j.bmcl.2012.02.104
PubMed: 22437117
Machine-readable: REST API RDF

Publication